Massachusetts Financial Services Co. MA Cuts Position in Agilent Technologies, Inc. $A

Massachusetts Financial Services Co. MA reduced its position in Agilent Technologies, Inc. (NYSE:A) by 6.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,434,385 shares of the medical research company’s stock after selling 793,002 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Agilent Technologies were worth $1,595,953,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the business. Capital A Wealth Management LLC lifted its position in Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after buying an additional 212 shares in the last quarter. Davis Capital Management purchased a new position in shares of Agilent Technologies in the 3rd quarter valued at $28,000. State of Wyoming acquired a new position in shares of Agilent Technologies during the 2nd quarter valued at $35,000. SJS Investment Consulting Inc. lifted its holdings in shares of Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock valued at $41,000 after acquiring an additional 312 shares in the last quarter. Finally, Salomon & Ludwin LLC boosted its position in Agilent Technologies by 242.5% during the 3rd quarter. Salomon & Ludwin LLC now owns 363 shares of the medical research company’s stock worth $51,000 after purchasing an additional 257 shares during the period.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at $5,017,200. This trade represents a 27.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Stock Performance

Shares of A stock opened at $139.68 on Friday. The stock has a market capitalization of $39.60 billion, a price-to-earnings ratio of 30.56, a PEG ratio of 4.05 and a beta of 1.29. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The company’s 50-day simple moving average is $144.41 and its 200-day simple moving average is $133.45. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.01. The firm had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.7%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.32%.

Analysts Set New Price Targets

A has been the topic of several analyst reports. TD Cowen raised their target price on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. Robert W. Baird boosted their target price on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 25th. Wells Fargo & Company raised their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. UBS Group upped their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Finally, Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $163.31.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.